Recent EVAX News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/27/2023 08:45:09 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/25/2023 08:45:04 PM
- Evaxion Partners With Pharmaceutical Company Afrigen Biologics to Develop Novel mRNA Vaccine Against Gonorrhea • GlobeNewswire Inc. • 09/20/2023 12:26:00 PM
- Evaxion expands preclinical bacterial vaccine pipeline in collaboration with leading pharmaceutical company • GlobeNewswire Inc. • 09/18/2023 12:23:00 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 09/13/2023 08:45:24 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/11/2023 12:17:07 PM
- Revolutionizing Vaccine Discovery: New Data Validates Evaxion AI Platform, Offering Promise to Reduce Risk and Cost in Infectious Disease Vaccine Development • GlobeNewswire Inc. • 09/11/2023 12:17:00 PM
- Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend] • Edgar (US Regulatory) • 09/07/2023 08:45:04 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/31/2023 04:15:12 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/29/2023 01:22:42 PM
- Evaxion announces Executive Management Changes to strengthen the AI-strategy • GlobeNewswire Inc. • 08/29/2023 12:30:00 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 08/25/2023 09:00:53 PM
- Evaxion Announces Business Update and Second Quarter 2023 Financial Results • GlobeNewswire Inc. • 08/18/2023 03:57:08 PM
- Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend] • Edgar (US Regulatory) • 08/18/2023 01:28:59 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/17/2023 08:58:50 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/17/2023 08:45:16 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/11/2023 08:45:16 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/04/2023 08:45:24 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/01/2023 11:00:06 AM
- Evaxion announces financing commitments totaling up to USD 20 million with Negma Group • GlobeNewswire Inc. • 08/01/2023 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/31/2023 08:45:09 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/31/2023 11:00:07 AM
- Evaxion presents promising results on EVX-B1, an AI-designed vaccine against Staphylococcus aureus • GlobeNewswire Inc. • 07/31/2023 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/11/2023 01:14:39 PM
- Evaxion’s AI technology identifies cancer vaccine targets associated with longer progression-free survival of melanoma patients in the EVX-01 Phase 1 clinical trial • GlobeNewswire Inc. • 06/03/2023 09:00:00 PM
Volcon Announces First Shipment of Newly Updated Grunt EVO Electric Motorcycle Units • VLCN • Sep 29, 2023 10:16 AM
Integrated Ventures Reports $3,862,849 In Yearly Mining Revenues With 162 Bitcoins Produced • INTV • Sep 29, 2023 10:00 AM
Branded Legacy Inc. Unveils Exciting Q4 2023 Milestones and Forges Ahead with Key Partnerships • BLEG • Sep 28, 2023 10:44 AM
UC Asset Signed MOU with Tenant to Build 8000 sq ft Cannabis Property • UCASU • Sep 28, 2023 9:00 AM
Goldshore Summer Field Program Identifies Five New Gold Trends Including Two High Grade Copper-Gold Trends • GSHRF • Sep 28, 2023 8:03 AM
SciSparc Announces Expected Implementation of 1-for-26 Reverse Share Split • SPRC • Sep 27, 2023 9:49 AM